Plexus (NASDAQ:PLXS) Announces Quarterly Earnings Results

Key Points

• Plexus (NASDAQ:PLXS) reported a quarterly earnings of $1.87 per share, surpassing analysts' expectations by $0.03.
• The company's stock price experienced a decline, trading down $4.23 to $146.10 during midday trading on the release day.
• Insiders have sold a total of 15,856 shares worth $2,142,440 in the last quarter, indicating insider selling activity amidst recent earnings announcements.

Plexus (NASDAQ:PLXS - Get Free Report) announced its earnings results on Wednesday. The technology company reported $2.14 EPS for the quarter, topping the consensus estimate of $1.84 by $0.30, Briefing.com reports. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business's quarterly revenue was up .7% on a year-over-year basis. During the same period last year, the company posted $1.85 EPS. Plexus updated its Q1 2026 guidance to 1.660-1.810 EPS.

Plexus Stock Down 2.8%

PLXS opened at $146.10 on Thursday. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $172.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58. The company has a market capitalization of $3.94 billion, a P/E ratio of 24.89 and a beta of 0.80. The stock has a fifty day moving average of $140.44 and a 200-day moving average of $133.36.

Insiders Place Their Bets

In other Plexus news, COO Oliver K. Mihm sold 2,102 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the completion of the transaction, the chief operating officer owned 21,155 shares of the company's stock, valued at approximately $2,759,246.65. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total value of $215,550.00. Following the transaction, the chief executive officer directly owned 69,214 shares of the company's stock, valued at approximately $9,946,051.80. The trade was a 2.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,856 shares of company stock valued at $2,142,440 over the last 90 days. 1.76% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PLXS. AQR Capital Management LLC raised its stake in Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company's stock worth $1,074,000 after acquiring an additional 4,255 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Plexus by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company's stock worth $2,046,000 after acquiring an additional 705 shares in the last quarter. United Services Automobile Association acquired a new position in Plexus during the first quarter worth about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Plexus by 12.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company's stock worth $10,197,000 after acquiring an additional 9,078 shares in the last quarter. Finally, Cetera Investment Advisers acquired a new position in Plexus during the second quarter worth about $309,000. Institutional investors and hedge funds own 94.45% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on PLXS shares. Needham & Company LLC decreased their price target on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research note on Thursday, July 24th. Williams Trading set a $165.00 price target on shares of Plexus in a research note on Monday, September 22nd. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Plexus in a research note on Wednesday, October 8th. Stifel Nicolaus set a $140.00 price target on shares of Plexus in a research note on Thursday, July 24th. Finally, Benchmark raised their price target on shares of Plexus from $160.00 to $165.00 and gave the stock a "buy" rating in a research note on Monday, September 22nd. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $155.60.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.